DA-033 20 (Abilify mycite 20 mg)
Generic Name: aripiprazole
Pill with imprint DA-033 20 is White, Round and has been identified as Abilify mycite 20 mg. It is supplied by Otsuka Pharmaceutical Co., Ltd.
Abilify MyCite is used in the treatment of bipolar disorder; depression; schizophrenia and belongs to the drug class atypical antipsychotics. Risk cannot be ruled out during pregnancy. Abilify MyCite 20 mg is not a controlled substance under the Controlled Substance Act (CSA).
Images for DA-033 20
- Generic Name:
- DA-033 20
- 20 mg
- Prescription only
- Drug Class:
- Atypical antipsychotics
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Otsuka Pharmaceutical Co., Ltd
- National Drug Code (NDC):
More about Abilify MyCite (aripiprazole)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Interactions
- Support Group
- 0 Reviews – Add your own review/rating
- Drug class: atypical antipsychotics
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.